Cancer Research

The global healthcare landscape is currently grappling with an annual toll of approximately 250,000 lives lost to brain tumors, a statistic that underscores the critical need for earlier and more precise diagnostic interventions. While magnetic resonance imaging remains the gold standard for

The blue residues found on the walls of the tombs in the Valley of the Kings have unexpectedly become the foundation for a sophisticated leap in medical diagnostics. Known as Egyptian blue, this pigment was initially synthesized roughly 4,500 years ago, marking a pivotal moment in the history of

The fundamental shift in managing Diffuse Large B-cell Lymphoma has transitioned from standardized salvage chemotherapy to a highly personalized approach utilizing engineered immune cells that target cancer with surgical precision. For decades, the therapeutic trajectory for patients who did not

Ivan Kairatov is a seasoned expert in biopharmaceutical research and development, possessing a profound understanding of the technological shifts currently reshaping oncology. With a career dedicated to navigating the complexities of drug innovation, he has a unique perspective on how precision

The clinical landscape of modern oncology is undergoing a profound transformation as biotechnology firms successfully engineer specialized immune cells to target and eliminate aggressive blood cancers that have developed a resistance to conventional medical interventions. Imugene Limited, a

Modern oncology is currently witnessing a paradigm shift where the brute force of systemic chemotherapy is being replaced by sophisticated molecular delivery systems designed to spare healthy tissue. While traditional treatments often ravage the entire body to reach a localized tumor, the